Lifecore Biomedical
(NASDAQ) LFCR
Lifecore Biomedical Financials at a Glance
Market Cap
$143.91M
Revenue (TTM)
$147.12M
Net Income (TTM)
$33.88M
EPS (TTM)
$-1.30
P/E Ratio
-2.94
Dividend
$0.00
Beta (Volatility)
1.21 (Average)
Dividend
$0.00
Beta (Volatility)
1.21 (Average)
Price
$3.83
Volume
23,077
Open
$3.71
Price
$3.83
Volume
23,077
Open
$3.71
Previous Close
$3.83
Daily Range
$3.71 - $3.87
52-Week Range
$3.63 - $8.98
Dividend
$0.00
Beta (Volatility)
1.21 (Average)
Price
$3.83
Volume
23,077
Open
$3.71
Previous Close
$3.83
Daily Range
$3.71 - $3.87
52-Week Range
$3.63 - $8.98
LFCR News
Why Landec Stock Crashed on Thursday
Are You Expecting This from Landec?
LFCR: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Lifecore Biomedical
Industry
Life Sciences Tools and Services
Sector
Health CareEmployees
382
CEO
Paul Josephs
Website
www.lifecore.comHeadquarters
Chaska, MN 55318, US
LFCR Financials
Key Financial Metrics (TTM)
Gross Margin
32%
Operating Margin
-3%
Net Income Margin
-23%
Return on Equity
-76%
Return on Capital
-2%
Return on Assets
-15%
Earnings Yield
-34.01%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$143.91M
Shares Outstanding
37.48M
Volume
23.08K
Short Interest
0.00%
Avg. Volume
264.47K
Financials (TTM)
Gross Profit
$40.30M
Operating Income
$17.25M
EBITDA
$8.81M
Operating Cash Flow
$206.00K
Capital Expenditure
$13.41M
Free Cash Flow
$13.62M
Cash & ST Invst.
$8.27M
Total Debt
$130.82M
Lifecore Biomedical Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$44.41M
+36.4%
Gross Profit
$15.90M
+43.4%
Gross Margin
35.80%
N/A
Market Cap
$143.91M
N/A
Market Cap/Employee
$274.64K
N/A
Employees
524
N/A
Net Income
$7.97M
-21.3%
EBITDA
$5.89M
+500.8%
Quarterly Fundamentals
Net Cash
$126.44M
-3.7%
Accounts Receivable
$33.82M
+67.6%
Inventory
$29.09M
-25.8%
Long Term Debt
$142.40M
+12.6%
Short Term Debt
$1.51M
-69.2%
Return on Assets
-14.59%
N/A
Return on Invested Capital
-2.13%
N/A
Free Cash Flow
$3.61M
+142.1%
Operating Cash Flow
$5.57M
+191.1%